Cargando…

Designing tuberculosis vaccine efficacy trials – lessons from recent studies

Introduction: Tuberculosis (TB) is the leading infectious killer globally and new TB vaccines will be crucial to ending the epidemic. Since the introduction in 1921 of the only currently licensed TB vaccine, BCG, very few novel vaccine candidates or strategies have advanced into clinical efficacy tr...

Descripción completa

Detalles Bibliográficos
Autor principal: Ginsberg, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492041/
https://www.ncbi.nlm.nih.gov/pubmed/30892969
http://dx.doi.org/10.1080/14760584.2019.1593143

Ejemplares similares